Treg cells act to dampen antitumor immunity by suppressing the effector functions of a variety of immune cells, including Th1 cells [56–58], CD8+ T cells [5], NK cells [59], and tumor-infiltrating DCs [60]. The gene discussed is CD8A; the disease is neoplasm.